Adaptive Topical Compositions of Dutasteride for Specialized Environments
Legal Citation
Summary of the Inventive Concept
The present inventive concept relates to specialized topical compositions of dutasteride adapted for unique operational environments, including extreme weather conditions, high-altitude environments, sensitive skin, disaster relief, and high-security needs.
Background and Problem Solved
The original patent disclosed topical compositions of dutasteride for preventing hair loss and stimulating hair growth. However, these compositions may not be suitable for specific environments or populations, such as extreme weather conditions, high-altitude environments, or individuals with sensitive skin. The present inventive concept addresses these limitations by providing adaptive topical compositions of dutasteride that cater to these niche requirements.
Detailed Description of the Inventive Concept
The inventive concept encompasses five specialized variations of topical compositions of dutasteride. Firstly, a composition formulated to withstand temperatures above 40°C and humidity above 80% for use in extreme weather conditions. Secondly, a method for preventing hair loss in high-altitude environments, where the composition is adapted to counteract the effects of low air pressure and low oxygen levels. Thirdly, a composition for stimulating hair growth in individuals with sensitive skin, incorporating a soothing agent selected from aloe vera, chamomile, and green tea. Fourthly, a kit for disaster relief, comprising a topical composition of dutasteride, a protective ointment, and a set of instructions for use in emergency situations. Lastly, a system for high-security needs, where the composition is formulated to be tamper-evident and to prevent unauthorized access.
Novelty and Inventive Step
The inventive concept's novelty lies in its adaptation of dutasteride compositions for specific, niche environments and populations, which is not obvious from the original patent. The inventive step involves the development of specialized formulations and systems that address the unique challenges and requirements of these environments and populations.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept could include compositions adapted for use in space exploration, military operations, or other extreme environments. Variations of the kit for disaster relief could include additional components, such as a first-aid guide or a communication device.
Potential Commercial Applications and Market
The inventive concept has significant commercial potential in various industries, including pharmaceuticals, cosmetics, and disaster relief. The target market includes individuals and organizations operating in extreme environments, as well as those requiring specialized hair care solutions for sensitive skin or high-security needs.
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Pharmaceutical formulations, specifically topical compositions for hair loss treatment involving 5α-reductase inhibitors, requiring expertise in pharmaceutical chemistry, drug delivery systems, and dermatological formulation techniques
Person of Ordinary Skill (PHOSITA) Profile
A pharmaceutical formulation scientist with advanced degree (MS/PhD), experience in drug delivery, knowledge of excipients, understanding of topical composition design, and familiarity with hair loss treatment technologies
Obviousness Rationale
A PHOSITA would recognize that the specialized dutasteride compositions represent predictable variations of the source patent's core formulation by applying standard pharmaceutical engineering techniques. The fundamental composition remains consistent, with modifications addressing specific environmental or user requirements using known pharmaceutical strategies. These adaptations represent routine optimization within the established framework of the original topical dutasteride composition.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,556 |
|---|---|
| Title | Topical compositions of dutasteride |
| Assignee(s) | SHILPA MEDICARE LIMITED |